ICON plc
ICON lists population PK, PK/PD, exposure-response modeling, trial simulation, first-in-human dose prediction, and formulation-related IVIVC. These are service disclosures, not independent evidence of success for an individual project.
Corporate information
- Company entity
- ICON plc
- Headquarters / principal office
- Leopardstown, Dublin, Ireland ↗
- Founded
- 1990 ↗
- Ownership / capital status
- Publicly tradedNasdaq ICLR ↗
- Official corporate reference
- https://www.iconplc.com/solutions/early-clinical/quantitative-pharmacology-and-pharmacometrics?Language=ja ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-04 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Start with public sources and capability boundaries; company claims are not independent certification.
Ask AI ↗Public evidence snapshot
ICON lists population PK, PK/PD, exposure-response modeling, trial simulation, first-in-human dose prediction, and formulation-related IVIVC. These are service disclosures, not independent evidence of success for an individual project.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.
Original sources
- ICON plc — official disclosure
- Explicit company formation history
- Official investor FAQ / exchange listing